Long--Term Free Survival of Two Class III β-Thalassemic Patients after Non-Myeloablative Stem Cell Transplantation

At present, hematopoietic stem cell transplantation is the only curative treatment for β thalassemia patients. Conventional myeloablative stem cell transplantation is associated with significant morbidity and mortality, and non-myeloablative stem cell transplantation is associated with high graft fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Adib Sereshki, Mohammad Mahdi, Bahar, Babak, Ghavamzadeh, Ardeshir, Mousavi, Seyed Asadollah, Alimoghaddam, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231797/
https://www.ncbi.nlm.nih.gov/pubmed/32461795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231797/
https://www.ncbi.nlm.nih.gov/pubmed/32461795

Ejemplares similares